Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP768680.RAlGfSWVHravli2bCAEvMBwyslEJDMHjeJce0r3fFu3u4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP768680.RAlGfSWVHravli2bCAEvMBwyslEJDMHjeJce0r3fFu3u4130_assertion type Assertion NP768680.RAlGfSWVHravli2bCAEvMBwyslEJDMHjeJce0r3fFu3u4130_head.
- NP768680.RAlGfSWVHravli2bCAEvMBwyslEJDMHjeJce0r3fFu3u4130_assertion description "[The clinical signs (hepatomegaly, splenomegaly and B-symptoms, clinical staging) and laboratory data (hemoglobin, white cell count (WBCs), platelet count, and bone marrow infiltration) were not significantly different between NHL subgroup with cyclin Dl over expression and that with normal cyclin Dl expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP768680.RAlGfSWVHravli2bCAEvMBwyslEJDMHjeJce0r3fFu3u4130_provenance.
- NP768680.RAlGfSWVHravli2bCAEvMBwyslEJDMHjeJce0r3fFu3u4130_assertion evidence source_evidence_literature NP768680.RAlGfSWVHravli2bCAEvMBwyslEJDMHjeJce0r3fFu3u4130_provenance.
- NP768680.RAlGfSWVHravli2bCAEvMBwyslEJDMHjeJce0r3fFu3u4130_assertion SIO_000772 17607588 NP768680.RAlGfSWVHravli2bCAEvMBwyslEJDMHjeJce0r3fFu3u4130_provenance.
- NP768680.RAlGfSWVHravli2bCAEvMBwyslEJDMHjeJce0r3fFu3u4130_assertion wasDerivedFrom befree-20140225 NP768680.RAlGfSWVHravli2bCAEvMBwyslEJDMHjeJce0r3fFu3u4130_provenance.
- NP768680.RAlGfSWVHravli2bCAEvMBwyslEJDMHjeJce0r3fFu3u4130_assertion wasGeneratedBy ECO_0000203 NP768680.RAlGfSWVHravli2bCAEvMBwyslEJDMHjeJce0r3fFu3u4130_provenance.